InvestorsHub Logo
Followers 0
Posts 15
Boards Moderated 0
Alias Born 07/06/2012

Re: None

Monday, 07/23/2012 5:17:36 PM

Monday, July 23, 2012 5:17:36 PM

Post# of 80868
It's obvious to me the numbers aren't going to be that great if they had to seek funding and dilute again.

This Q2 we'll get to see what kind of an impact Eurpac had on sales. High expectations were placed for that.

I bet we see something along the lines of..

DENVER, CO-July 14, 2011 (PRNewswire) -- MusclePharm Corporation, a Nevada corporation (“MusclePharm” or the “Company”) (OTCBB: MSLP), an expanding U.S. nutritional supplement company, is pleased to announce MusclePharm's preliminary financial results for the first quarter ending June 30, 2011.

On a preliminary basis, the Company expects unaudited gross revenues for the three months ended June 30, 2011 of approximately $4,000,000, an increase of approximately 854% as compared to gross revenues of $468,109 during the corresponding three month period ended June 30, 2010.

The Company expects to report a net loss for the three months ended June 30, 2011, but is continually making the necessary changes to become profitable in the near future.

Change a few dates around and it'll look the exact same. Nice revenue increase. No profit. Toxic finance. Sinking stock price into oblivion. Worst of all, people stressing the words POTENTIAL and HUGE REVENUE..